CME Group Inc. $CME Shares Bought by Element Capital Management LLC

Element Capital Management LLC grew its stake in CME Group Inc. (NASDAQ:CME) by 12.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,706 shares of the financial services provider’s stock after acquiring an additional 3,706 shares during the period. CME Group accounts for approximately 4.4% of Element Capital Management LLC’s holdings, making the stock its 6th largest position. Element Capital Management LLC’s holdings in CME Group were worth $9,204,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. SG Americas Securities LLC grew its position in shares of CME Group by 345.2% in the 4th quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock valued at $64,965,000 after acquiring an additional 184,459 shares during the period. Dover Advisors LLC raised its holdings in shares of CME Group by 95.5% in the 3rd quarter. Dover Advisors LLC now owns 5,597 shares of the financial services provider’s stock valued at $1,512,000 after purchasing an additional 2,734 shares during the period. FLC Capital Advisors acquired a new stake in CME Group in the 4th quarter valued at about $2,122,000. NEOS Investment Management LLC lifted its stake in CME Group by 32.5% in the 3rd quarter. NEOS Investment Management LLC now owns 50,977 shares of the financial services provider’s stock valued at $13,773,000 after purchasing an additional 12,503 shares during the last quarter. Finally, First Bank & Trust bought a new position in CME Group during the fourth quarter worth about $1,325,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

NASDAQ:CME opened at $252.54 on Thursday. The stock has a market cap of $91.51 billion, a P/E ratio of 21.55, a PEG ratio of 2.92 and a beta of 0.21. The stock has a 50 day simple moving average of $282.02 and a 200 day simple moving average of $287.75. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 1-year low of $244.56 and a 1-year high of $329.16.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the previous year, the company posted $2.80 EPS. The firm’s quarterly revenue was up 14.5% on a year-over-year basis. Research analysts anticipate that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be paid a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.1%. CME Group’s dividend payout ratio is 44.37%.

Insider Transactions at CME Group

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider owned 27,702 shares in the company, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CME. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and raised their price objective for the company from $316.00 to $323.00 in a research report on Thursday, June 11th. Wall Street Zen upgraded CME Group from a “sell” rating to a “hold” rating in a research note on Saturday, June 13th. UBS Group reaffirmed an “overweight” rating on shares of CME Group in a report on Monday. Jefferies Financial Group decreased their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Finally, Piper Sandler set a $320.00 price objective on shares of CME Group in a report on Wednesday. Eleven analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $305.18.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME announced a planned leadership transition that appears orderly: longtime CEO Terry Duffy will move to executive chairman in March 2027, while President and CFO Lynne Fitzpatrick will become CEO. Investors may view the succession plan as reducing near-term key-person risk. Article Title
• Neutral Sentiment: Management’s transition also signals continuity, since Fitzpatrick already serves as president and CFO and has been part of CME’s leadership team. That makes the handoff less disruptive than an outside hire. Article Title
• Negative Sentiment: Duffy said CME plans to sue the CFTC over perpetual futures, highlighting a more confrontational regulatory backdrop. The dispute could add legal uncertainty and revive investor concerns about competition from new crypto derivatives products. Article Title
• Negative Sentiment: Kraken’s launch of perpetual futures for U.S. traders through a CFTC-regulated venue adds to fears that competitors could chip away at CME’s crypto derivatives franchise over time. Article Title

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.